According to analysts at Market Business Insights, the United States Compression Therapy Market size is worth USD 4.12 Billion in 2025 and is projected to reach USD 7.48 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 6.15% from 2026 to 2035. Key trends include rising demand for advanced compression garments, increasing adoption of programmable pneumatic compression systems, expanding home healthcare services, growing prevalence of chronic venous disorders, advanced textile innovations, digital patient monitoring, and increasing integration of connected therapeutic devices into vascular care programs.
United States Compression Therapy Market Overview
The United States Compression Therapy Market is witnessing steady growth due to the increasing prevalence of chronic venous diseases, lymphedema, deep vein thrombosis, and other vascular disorders. Compression therapy plays an essential role in improving blood circulation, reducing edema, accelerating wound healing, and supporting postoperative recovery. Hospitals, specialty clinics, rehabilitation centers, and home healthcare providers are increasingly adopting advanced compression solutions to improve patient outcomes and reduce long-term healthcare expenditure.
The growing geriatric population, rising obesity rates, diabetes prevalence, and increasing incidence of chronic venous insufficiency are significantly driving demand for compression garments, bandages, and pneumatic compression devices. Compression garments account for more than 36% of total product demand due to their broad clinical applicability, cost efficiency, and suitability for long-term vascular disease management.
Technological advancements in programmable pneumatic systems, breathable medical textiles, antimicrobial fabrics, and connected therapeutic devices are further supporting market expansion. Healthcare providers are increasingly adopting dynamic compression technologies that deliver controlled sequential pressure and enable personalized treatment protocols. Digital monitoring capabilities, wearable pressure sensors, and remote patient engagement platforms are also improving treatment adherence and clinical efficiency.
The expansion of home healthcare represents another important growth opportunity as healthcare organizations increasingly shift chronic disease management beyond traditional hospital settings. Portable compression devices, reusable garments, and simplified treatment systems allow patients to continue therapy at home while reducing hospital visits and improving treatment convenience. The home healthcare segment is projected to grow at over 7% CAGR during the forecast period.
Furthermore, increasing investments in advanced vascular care, digital healthcare infrastructure, and evidence-based wound management are encouraging manufacturers to develop integrated therapeutic solutions. Artificial intelligence, remote monitoring, and connected healthcare platforms are emerging as important technological trends, supporting personalized treatment and improved clinical decision-making.
Overall, the United States Compression Therapy Market is expected to experience sustained long-term growth as healthcare providers prioritize preventive vascular care, decentralized treatment delivery, advanced therapeutic technologies, and improved patient adherence.
Tactile Medical Introduced Enhanced Digital Patient Engagement Capabilities for Compression Therapy
- March 2025 — According to the reference research, Tactile Medical introduced enhanced digital patient engagement capabilities supporting remote adherence monitoring for compression therapy programs, improving treatment visibility and supporting continuity of care across home healthcare environments.
Key Takeaways from the Report
- The increasing prevalence of chronic venous disorders, lymphedema, deep vein thrombosis, and vascular complications is accelerating demand for advanced compression therapy solutions across the United States.
- Compression garments account for more than 36% of total product demand, supported by their extensive application in chronic venous disease management, postoperative recovery, and long-term home healthcare.
- Home healthcare is projected to expand at over 7% CAGR as portable therapeutic devices, reusable compression garments, and decentralized patient management programs gain wider adoption.
- Dynamic compression technologies contribute more than 30% of technology investments as healthcare providers increasingly adopt programmable pneumatic systems and personalized treatment protocols.
- Chronic venous disease management generates more than 40% of recurring institutional procurement activity, reinforcing sustained demand across hospitals and specialty vascular clinics.
- Digital patient monitoring supports more than 25% of premium product introductions, reflecting increasing integration of connected therapeutic devices, wearable sensors, and remote adherence tracking.
- Advanced medical textiles, breathable compression garments, antimicrobial materials, and AI-enabled patient engagement platforms are creating new opportunities for manufacturers and healthcare service providers.
Top Players
- 3M
- Cardinal Health
- Medtronic plc
- Essity AB
- Paul Hartmann AG
- SIGVARIS Group
- Lohmann & Rauscher
- Arjo AB
- Bio Compression Systems, Inc.
- Enovis Corporation
- Julius Zorn GmbH
- Tactile Medical
- Huntleigh Healthcare
- Smith+Nephew
Report Coverage
Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.
Latest Announcement
- February 2026 — According to the reference research, Arjo AB introduced an upgraded intermittent pneumatic compression platform featuring enhanced programmable treatment protocols for rehabilitation environments, supporting personalized compression therapy and improved clinical workflow efficiency.